News

Macquarie Forecasts Increased US Crude and Product Stocks

Macquarie Forecasts Increased US Crude and Product Stocks

Macquarie Projects Increased US Crude Inventories

Recently, Macquarie's team of strategists provided insights into the trends surrounding US crude inventories, predicting a notable rise for the week ending January 10. This projection highlights the dynamic nature of the energy market and how various factors can influence stock levels.

Analyst Expectations on Crude Inventory Changes

The analysts anticipate an increase of approximately 3.0 million barrels in US crude inventories. This forecast marks a departure from the previously expected build of 4.3 million barrels, especially compared to last week, where a modest draw of 1.0 million barrels was recorded.

Factors Influencing Crude Runs and Imports

Macquarie's analysis includes an expectation of a reduction in refinery crude runs by 0.4 million barrels per day (MBD). Additionally, they foresee a slight decline in net imports, with exports down by 0.2 MBD and imports decreasing by 0.3 MBD. Such shifts reflect not only market demand but also ongoing adjustments in the global supply chain.

The Impact of Seasonal Variability

The timing surrounding cargo arrivals plays a critical role in determining the balance of crude stocks. Macquarie cautions that variations might arise this week due to year-end timing effects. This observation underscores the complexities involved in accurately projecting inventory levels amid fluctuating conditions.

Domestic Supply Projections and Weather Considerations

In addition to changes in inventory, Macquarie predicts a slight increase in implied domestic supply, estimating growth of 0.4 MBD. This comes following a notably weaker figure from the previous week. However, they highlight winter weather patterns that could impact the accuracy of these estimates, indicating that environmental factors continue to influence energy production.

Strategic Petroleum Reserve Inventory Outlook

Furthermore, Macquarie foresees a minor build in the Strategic Petroleum Reserve (SPR), estimating an increase of 0.5 million barrels for the week. This move implies a strategic reaction to the current market conditions and is a point of interest for energy policies moving forward.

Forecast for Gasoline and Other Product Stocks

On the product side of the spectrum, Macquarie's forecasts indicate a significant rise in gasoline inventories, projecting an increase of 4.4 million barrels. There are also expected rises in distillate and jet fuel stocks, anticipated at 1.3 million barrels and 1.9 million barrels respectively. The expected growth across these product categories may reflect broader trends in consumer and industrial activity as well.

Total Implied Demand Expectations

Taking all these factors into account, total implied demand for gasoline, distillate, and jet fuel is projected to be around 13.7 million barrels per day for the week ending January 10. This data provides a holistic view of the energy landscape and serves as a barometer for future market conditions.

Frequently Asked Questions

What is Macquarie's recent forecast for US crude inventories?

Macquarie recently predicted an increase of about 3.0 million barrels in US crude inventories for the week ending January 10.

How do crude imports and exports factor into this forecast?

Macquarie expects a slight decrease in crude imports by 0.3 MBD and exports by 0.2 MBD, indicating shifts in the supply chain.

What role does weather play in inventory projections?

Winter weather patterns are anticipated to impact the accuracy of inventory estimates, which may lead to variabilities.

How much is the Strategic Petroleum Reserve expected to increase?

Macquarie forecasts a minor increase in the Strategic Petroleum Reserve of about 0.5 million barrels.

What is the projected demand for gasoline and related products?

The total implied demand for gasoline, distillate, and jet fuel is projected around 13.7 MBD for the relevant week.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Ris-Rez May Set New Standard in Relapsed SCLC

Updated Category News Views 4

The Game-Changing Results Innovation in pharmaceuticals sometimes feels like a waiting game, but when a fresh breakthrough like this rolls in, it lights up the whole landscape. Risvutatug rezetecan, or Ris-Rez for short, has shown promising potential in the fight against relapsed small-cell lung cancer (SCLC) that has progressed after platinum-based therapy. Survival...

Continue Reading
PwC US and India Unite for Global Consultancy Powerhouse

Updated Category News Views 6

Rearranging the Consultancy Chessboard Piling onto the game of consultancy realignments, PwC just made a move reminiscent of playing strategy poker. They're tossing together PwC US and PwC India's advisory capabilities for a new joint venture. It’s like pushing two puzzle pieces to make a single colorful picture that stretches from the U.S. all the way to the...

Continue Reading
UWM Faces Class Action Deadline: Key Insights for Investors

Updated Category News Views 2

The High Stakes Reality for UWM Investors If there's one thing that's certain in this jittery world of investing, it's that losses have a way of waking you up. Right now, anyone tied up with UWM Holdings Corporation (NYSE: UWMC) shares needs to keep their wits about them; we're barreling toward an October 13, 2026 deadline for a class action lawsuit. The clock's ticking...

Continue Reading
Regeneron Faces Legal Heat: Lead Plaintiff Deadline Looms

Updated Category News Views 0

Regeneron’s Tight Spot: Legal Showdown Well, here we go again—Regeneron Pharmaceuticals (NASDAQ:REGN) is under some serious heat. If you're an investor who faced significant losses with this biotech juggernaut, remember that the clock’s ticking down to the wire. By tomorrow, September 14, 2026, you need to decide if you're going to throw your hat in the ring for...

Continue Reading
Tam-Peli Steps Up in SCLC Battle: Trial Insights

Updated Category News Views 5

Noteworthy Developments in Small-Cell Lung Cancer Treatment Let's dive into a story straight from the world of small-cell lung cancer (SCLC) that doesn't take any prisoners. The antidote making waves is tambotatug pelitecan, or Tam-Peli for short, showcasing its might in the unrelenting fight against relapsed SCLC. The phase III TAISHAN-302 trial puts Tam-Peli...

Continue Reading
MRI Surveillance Gains Ground in Lung Cancer Care

Updated Category News Views 3

Shifting the Standard: MRI's Rise in SCLC Treatment Here's a twist that baffles the traditionalists—ditch the prophylactic cranial irradiation (PCI) and catch clearer days with MRI surveillance for small-cell lung cancer (SCLC). The latest international phase III MAVERICK trial might just redraw the lines on what's considered standard care in this relentless disease....

Continue Reading
Surfing Dogs Ride Waves, Support Orphan Pets

Updated Category News Views 2

Waves, Paws, and Passion Who would've thought that dogs catching waves could also catch hearts and wallets? Well, that's exactly what's happening today at Del Mar Dog Beach with the 21st Annual Surf Dog Surf-A-Thon revving up the excitement. It's a sun-soaked day in Rancho Santa Fe, California, right in the thick of things at the longest-running dog surf competition. For...

Continue Reading
Trial Disappointment: No Significant Gains in NSCLC

Updated Category News Views 7

Dissecting the Nuances of the EVOKE-03/KEYNOTE-D46 Trial Every once in a while, we come across a trial that rattles cages in the research community. Today, it's the EVOKE-03/KEYNOTE-D46 trial, a collision of hope and hard-knock reality. This Phase 3 trial, which sought to explore the potential combo of sacituzumab govitecan (SG) and pembrolizumab on metastatic non-small...

Continue Reading
GORGIE Unleashes Berry Burst: Target's New Drink Star

Updated Category News Views 2

GORGIE Targets Taste Buds with Berry Burst Ever feel like you're missing out on that energy drink everyone seems to be raving about? Well, GORGIE's out there making some noise again, and this time it's got a new punchy player in the game: Berry Burst. It's not just another drink; it's shaking things up in the energy aisle with its exclusive launch at Target. Modern style...

Continue Reading
PANDAG G1 Debuts: Revolutionizing Lawn Care Efficiency

Updated Category News Views 4

The Future of Landscaping Unveiled Get this—PANDAG is set to shake things up at GaLaBau 2026 with their futuristic G1 autonomous mower. This isn't just another piece of lawn equipment; it's practically a tech marvel on wheels, weaving together LiDAR, AI Vision, RTK, and 4G tech to make it the ultimate multitasker for the landscaping industry. We're talking obstacle...

Continue Reading

Top 5 Most Recently Viewed Articles

Theravance Biopharma's YUPELRI® Receives Regulatory Green Light

Updated Category News Views 222

Theravance Biopharma's YUPELRI® Approves by China's NMPA Theravance Biopharma, Inc. (NASDAQ: TBPH) has announced a major achievement with the approval of YUPELRI® (revefenacin) by China’s National Medical Products Administration (NMPA). This landmark decision positions YUPELRI as the first once-daily nebulized long-acting muscarinic antagonist (LAMA) to be approved...

Continue Reading
Discover Passive Income Opportunities with SIX MINING's Innovative Platform

Updated Category News Views 233

Unleashing Passive Income Potential with SIX MINING SIX MINING is an innovative cryptocurrency investment platform established in the UK that is dedicated to creating an accessible environment for those interested in crypto mining. It aims to provide a green energy approach, allowing individuals from all backgrounds to benefit financially through easy-to-navigate...

Continue Reading
KARNO Linear Generator Gains Approval Under California RPS

Updated Category News Views 166

Hyliion Holdings Corp. (NYSE: HYLN) got its KARNO linear generator approved under California's Renewables Portfolio Standard (RPS), and that's no small feat. This move aligns perfectly with California's aggressive climate goals as it pushes for 60% of retail electricity sales to come from renewables by 2030, ramping up to full carbon neutrality by 2045. But let’s peel...

Continue Reading
nCino Reports Strong Preliminary Q1 Fiscal Year 2026 Results

Updated Category News Views 228

nCino Exceeds Revenue Expectations for First Quarter nCino, Inc. (NASDAQ: NCNO), a prominent provider of cutting-edge banking solutions, has proudly announced that its preliminary financial results for the recently concluded first quarter have surpassed the upper limits of the guidance it previously provided. These results encompass Total Revenues, Subscription Revenues,...

Continue Reading
Stantec's Strategic Role in Developing New Commercial Port

Updated Category News Views 123

Stantec's Role in the Development of a Modern Commercial Port Stantec is set to embark on an ambitious project to design and engineer a new commercial port of entry alongside design-build partners, Hensel Phelps and Jones Studio. This partnership has been awarded a significant contract worth $274.7 million, highlighting Stantec's expertise in transforming infrastructure...

Continue Reading